| Literature DB >> 23241361 |
Géraldine Martorella1, José Côté, Mélanie Racine, Manon Choinière.
Abstract
BACKGROUND: Most adults undergoing cardiac surgery suffer from moderate to severe pain for up to 6 days after surgery. Individual barriers and attitudes regarding pain and its relief make patients reluctant to report their pain and ask for analgesic medication, which results in inadequate pain management. More innovative educational interventions for postoperative pain relief are needed. We developed a Web-based nursing intervention to influence patient's involvement in postoperative pain management. The intervention (SOULAGE-TAVIE) includes a preoperative 30-minute Web-based session and 2 brief face-to-face postoperative booster sessions. The Web application generates reflective activities and tailored educational messages according to patients' beliefs and attitudes. The messages are transmitted through videos of a virtual nurse, animations, stories, and texts.Entities:
Mesh:
Year: 2012 PMID: 23241361 PMCID: PMC3799541 DOI: 10.2196/jmir.2070
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Figure 1Home page of the SOULAGE-TAVIE website showing the determine profile function and start intervention function.
Example of reflection activity on pain definition based on real-time answers to the question: “What is the pain intensity between 0 and 10 that you expect to feel the day after surgery?”
| Feedback | User response | |
|
| 0 to 3 | 7 to 10 |
| Descriptive/comparative | “Between 0 and 3, pain is considered mild. Most people feel moderate to severe pain the first day after cardiac surgery.” | “Some people feel severe pain (between 7 and 10) and, as they expected it, they think it is normal to endure it.” |
| Reinforcement message through persuasive communication | “You could feel pain higher than 4 if you move for example, although you should target a mild level of pain to facilitate your recovery.” | “Studies recommend maintaining a mild level of pain to promote a good recovery.” |
|
| “Do not let your pain exceed 4!” | “Do not let your pain exceed 4!’’ |
Example of tailored message according to score on the Pain Catastrophizing Scale (rumination subscale).
| Response | Profile | |
|
| Mild (score ≤ 2) | Moderate-high (score > 2) |
| Message | When you feel pain, you think about it sometimes but you are able to concentrate on something else. Bravo! It is good to have this attitude when dealing with pain. When people focus their mind on pain, they stop moving, it slows down their recovery, and can also lead to pain elevation. | When you are in pain, you tend to concentrate your mind on it. It is normal because pain is unpleasant! However, by doing so you stop thinking about solutions and you avoid doing your recovery activities to avoid pain. |
Figure 2Screening page of the SOULAGE-TAVIE website.
Figure 3Animated integration page of the SOULAGE-TAVIE website displaying case history and nurse’s advice.
Figure 4CONSORT flow diagram of participants.
Demographic and clinical characteristics of the participants in the control and experimental groups.
| Variables | Control group | Experimental group |
| |
|
|
|
| .81 | |
|
| Female | 5 (23) | 6 (20) |
|
|
| Male | 17 (77) | 24 (80) |
|
| Age, mean (SD) | 63.2 (9.9) | 64.6 (8.2) | .58 | |
|
|
|
| .89 | |
|
| Single | 1 (4) | 1 (3) |
|
|
| Married or free union | 14 (64) | 21 (70) |
|
|
| Separated/divorced/widowed | 7 (32) | 8 (27) |
|
|
|
|
| .11 | |
|
| Lives with spouse (with or without children) | 14 (64) | 22 (73) |
|
|
| Lives with family member or friend | 3 (14) | 0 (0) |
|
|
| Lives alone | 5 (22) | 8 (27) |
|
|
|
|
| .19 | |
|
| Primary | 6 (27) | 6 (20) |
|
|
| Secondary | 6 (27) | 8 (27) |
|
|
| High school | 2 (9) | 10 (33) |
|
|
| University | 8 (37) | 6 (20) |
|
|
|
|
| .10 | |
|
| Full time/part time | 10 (45) | 14 (47) |
|
|
| Unemployed/student | 3 (14) | 4 (13) |
|
|
| Retired | 9 (41) | 12 (40) |
|
|
|
|
| .77 | |
|
| < CAD $25,000 | 9 (41) | 10 (36) |
|
|
| < CAD $55,000 | 10 (45) | 12 (43) |
|
|
| ≥ CAD $55,000 | 3 (14) | 6 (21) |
|
|
| 9 (41) | 10 (33) | .57 | |
| Duration of chronic pain in months, mean (SD) | 111.3 (157.1) | 142.4 (187.5) | .70 | |
|
|
|
| .48 | |
|
| CABG | 11 (50) | 20 (69) |
|
|
| Valve replacement (VR) | 5 (23) | 4 (14) |
|
|
| CABG + VR | 6 (27) | 5 (17) |
|
| Presence of postoperative complication(s), n (%) | 15 (68) | 13 (45) | .10 | |
| Use of patient-controlled analgesia, n (%) | 13 (59) | 17 (59) | .97 | |
| Number of grafts, mean (SD) | 2.47 (1.0) | 3.29 (1.1) | .02 | |
| Anesthesia duration in minutes, mean (SD) | 204.9 (82.6) | 210 (70.2) | .82 | |
| Opioid dose during surgery expressed into morphine equivalents, mean (SD) | 51.0 (36.7) | 50.3 (35.7) | .95 | |
| Intensive care length of stay in hours, mean (SD) | 84.7 (202.7) | 32.0 (24.8) | .17 | |
| Postoperative length of stay in days, mean (SD) | 11.2 (9.6) | 7.5 (3.3) | .06 | |
Number and percentage of patients who reported severe pain interference (≥ 7/10) in specific activities as assessed by the Brief Pain Inventory (BPI) in the control and experimental groups.
| Activities | Day 1 | Day 2 | Day 3 | Day 7 | |||||
|
|
| n/N (%) |
| n/N (%) |
| n/N (%) |
| n/N (%) |
|
|
|
| n/aa |
| .06 |
| .19 |
| .42 | |
|
| Experimental group | n/aa |
| 2/21 (9) |
| 3/27 (11) |
| 4/30 (13) |
|
|
| Control group | n/aa |
| 5/14 (36) |
| 4/15 (27) |
| 4/18 (22) |
|
|
|
| n/aa |
| .50 |
| .98 |
| .02 | |
|
| Experimental group | n/aa |
| 4/26 (15) |
| 5/27 (18) |
| 1/30 (3) |
|
|
| Control group | n/aa |
| 4/17 (23) |
| 3/16 (19) |
| 5/19 (26) |
|
|
|
| .18 |
| .06 |
| .23 |
| .93 | |
|
| Experimental group | 4/25 (16) |
| 3/26 (11) |
| 3/27 (11) |
| 5/30 (17) |
|
|
| Control group | 6/18 (33) |
| 6/17 (35) |
| 4/16 (25) |
| 3/19 (16) |
|
|
|
| .23 |
| .28 |
| .04 |
| .06 | |
|
| Experimental group | 8/25 (32) |
| 8/26 (31) |
| 4/27 (15) |
| 3/30 (10) |
|
|
| Control group | 9/18 (50) |
| 8/17 (47) |
| 7/16 (44) |
| 6/19 (31) |
|
a n/a: not applicable to the patients’ condition
Mean scores on the Barriers Questionnaire-II (BQ-II) for the control and experimental groups.
|
| Baseline, mean (SD) | Day 7, mean (SD) |
| |||||
|
|
| Experimental | Control | Experimental | Control | Group | Time | Interaction |
|
|
|
|
|
|
|
|
| |
|
| Secondary effects | 20.4 (12.4) | 25.1 (12.2) | 17.7 (14.7) | 26.9 (15.1) | .06 | .81 | .22 |
|
| Harmful effects | 12.6 (8.0) | 13.4 (8.5) | 10.6 (8.3) | 15.8 (7.3) | .18 | .80 | .02 |
|
| Fatalism | 1.8 (2.5) | 1.7 (2.6) | 2.2 (2.5) | 0.8 (1.0) | .23 | .46 | .07 |
|
| Communication | 11.1 (8.5) | 8.2 (6.4) | 9.7 (7.6) | 10.6 (7.7) | .62 | .65 | .07 |
| Global score on the BQ-II | 45.9 (25.9) | 47.9 (19.5) | 40.2 (29.4) | 53.3 (27.7) | .29 | .95 | .07 | |
Opioid dose after surgery expressed into milligrams (mg) of morphine equivalents for both control and experimental groups.
| Postsurgery day | Opioid dose (mg morphine) |
| |
|
| Control group | Experimental group |
|
| Day 1 | 21.9 (13.4) | 26.4 (16.2) | .65 |
| Day 2 | 18.8 (15.3) | 31.2 (23.2) | .006 |
| Day 3 | 13.3 (12.6) | 17.7 (15.4) | .11 |
| Day 7 | 3.2 (4.5) | 4.3 (7.1) | .57 |